Human immunodeficiency virus-infected adolescents

The first 50 patients in a New York City program

Donna C. Futterman, K. Hein, N. Reuben, R. Dell, N. Shaffer

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

To address the unique manifestations of human immunodeficiency virus (HIV) among adolescents aged 13 through 21 years, a comprehensive evaluation and treatment program for high-risk and HIV-positive adolescents was developed in New York City in 1987. Among HIV-infected youth, mean age of testing was 18.2 years. One third of the HIV-positive patients were female and four fifths were African-American or Hispanic. No significant differences were found between HIV-positive (n = 50) and HIV-negative (n = 43) patients for age at first intercourse, injecting or other illicit drug use, history of sexually transmitted diseases, or survival sex (exchange of sex for money or drugs). HIV-positive males were more likely than HIV-negative males to have engaged in anal intercourse and to report a history of sexual abuse. Among infected females, 82% acquired HIV through heterosexual intercourse. Almost half (48%) of HIV-positive adolescents had significant immune dysfunction at the time of their initial visit (CD4 <500/mm3) and were eligible for zidovudine. Many HIV-positive adolescents continued high-risk behaviors such as intercourse without condoms, particularly those with ongoing dependence on drugs or alcohol. With the epidemic of HIV infection increasing nationwide among adolescents, specialized, comprehensive programs are needed to counsel and treat HIV-infected adolescents and youth in high-risk situations.

Original languageEnglish (US)
Pages (from-to)730-735
Number of pages6
JournalPediatrics
Volume91
Issue number4
StatePublished - 1993

Fingerprint

HIV
Zidovudine
Coitus
Heterosexuality
Sex Offenses
Program Evaluation
Condoms
Street Drugs
Virus Diseases
Sexually Transmitted Diseases
Risk-Taking
Hispanic Americans
African Americans
Alcoholism
Substance-Related Disorders
Survival
Pharmaceutical Preparations

Keywords

  • acquired immunodeficiency syndrome
  • adolescence
  • epidemiology
  • heterosexuality
  • homosexuality
  • human immunodeficiency virus
  • sexual abuse
  • sexually transmitted diseases
  • substance abuse

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Human immunodeficiency virus-infected adolescents : The first 50 patients in a New York City program. / Futterman, Donna C.; Hein, K.; Reuben, N.; Dell, R.; Shaffer, N.

In: Pediatrics, Vol. 91, No. 4, 1993, p. 730-735.

Research output: Contribution to journalArticle

Futterman, DC, Hein, K, Reuben, N, Dell, R & Shaffer, N 1993, 'Human immunodeficiency virus-infected adolescents: The first 50 patients in a New York City program', Pediatrics, vol. 91, no. 4, pp. 730-735.
Futterman, Donna C. ; Hein, K. ; Reuben, N. ; Dell, R. ; Shaffer, N. / Human immunodeficiency virus-infected adolescents : The first 50 patients in a New York City program. In: Pediatrics. 1993 ; Vol. 91, No. 4. pp. 730-735.
@article{a35c3b8eafd743a3b72845b7b4cc8171,
title = "Human immunodeficiency virus-infected adolescents: The first 50 patients in a New York City program",
abstract = "To address the unique manifestations of human immunodeficiency virus (HIV) among adolescents aged 13 through 21 years, a comprehensive evaluation and treatment program for high-risk and HIV-positive adolescents was developed in New York City in 1987. Among HIV-infected youth, mean age of testing was 18.2 years. One third of the HIV-positive patients were female and four fifths were African-American or Hispanic. No significant differences were found between HIV-positive (n = 50) and HIV-negative (n = 43) patients for age at first intercourse, injecting or other illicit drug use, history of sexually transmitted diseases, or survival sex (exchange of sex for money or drugs). HIV-positive males were more likely than HIV-negative males to have engaged in anal intercourse and to report a history of sexual abuse. Among infected females, 82{\%} acquired HIV through heterosexual intercourse. Almost half (48{\%}) of HIV-positive adolescents had significant immune dysfunction at the time of their initial visit (CD4 <500/mm3) and were eligible for zidovudine. Many HIV-positive adolescents continued high-risk behaviors such as intercourse without condoms, particularly those with ongoing dependence on drugs or alcohol. With the epidemic of HIV infection increasing nationwide among adolescents, specialized, comprehensive programs are needed to counsel and treat HIV-infected adolescents and youth in high-risk situations.",
keywords = "acquired immunodeficiency syndrome, adolescence, epidemiology, heterosexuality, homosexuality, human immunodeficiency virus, sexual abuse, sexually transmitted diseases, substance abuse",
author = "Futterman, {Donna C.} and K. Hein and N. Reuben and R. Dell and N. Shaffer",
year = "1993",
language = "English (US)",
volume = "91",
pages = "730--735",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4",

}

TY - JOUR

T1 - Human immunodeficiency virus-infected adolescents

T2 - The first 50 patients in a New York City program

AU - Futterman, Donna C.

AU - Hein, K.

AU - Reuben, N.

AU - Dell, R.

AU - Shaffer, N.

PY - 1993

Y1 - 1993

N2 - To address the unique manifestations of human immunodeficiency virus (HIV) among adolescents aged 13 through 21 years, a comprehensive evaluation and treatment program for high-risk and HIV-positive adolescents was developed in New York City in 1987. Among HIV-infected youth, mean age of testing was 18.2 years. One third of the HIV-positive patients were female and four fifths were African-American or Hispanic. No significant differences were found between HIV-positive (n = 50) and HIV-negative (n = 43) patients for age at first intercourse, injecting or other illicit drug use, history of sexually transmitted diseases, or survival sex (exchange of sex for money or drugs). HIV-positive males were more likely than HIV-negative males to have engaged in anal intercourse and to report a history of sexual abuse. Among infected females, 82% acquired HIV through heterosexual intercourse. Almost half (48%) of HIV-positive adolescents had significant immune dysfunction at the time of their initial visit (CD4 <500/mm3) and were eligible for zidovudine. Many HIV-positive adolescents continued high-risk behaviors such as intercourse without condoms, particularly those with ongoing dependence on drugs or alcohol. With the epidemic of HIV infection increasing nationwide among adolescents, specialized, comprehensive programs are needed to counsel and treat HIV-infected adolescents and youth in high-risk situations.

AB - To address the unique manifestations of human immunodeficiency virus (HIV) among adolescents aged 13 through 21 years, a comprehensive evaluation and treatment program for high-risk and HIV-positive adolescents was developed in New York City in 1987. Among HIV-infected youth, mean age of testing was 18.2 years. One third of the HIV-positive patients were female and four fifths were African-American or Hispanic. No significant differences were found between HIV-positive (n = 50) and HIV-negative (n = 43) patients for age at first intercourse, injecting or other illicit drug use, history of sexually transmitted diseases, or survival sex (exchange of sex for money or drugs). HIV-positive males were more likely than HIV-negative males to have engaged in anal intercourse and to report a history of sexual abuse. Among infected females, 82% acquired HIV through heterosexual intercourse. Almost half (48%) of HIV-positive adolescents had significant immune dysfunction at the time of their initial visit (CD4 <500/mm3) and were eligible for zidovudine. Many HIV-positive adolescents continued high-risk behaviors such as intercourse without condoms, particularly those with ongoing dependence on drugs or alcohol. With the epidemic of HIV infection increasing nationwide among adolescents, specialized, comprehensive programs are needed to counsel and treat HIV-infected adolescents and youth in high-risk situations.

KW - acquired immunodeficiency syndrome

KW - adolescence

KW - epidemiology

KW - heterosexuality

KW - homosexuality

KW - human immunodeficiency virus

KW - sexual abuse

KW - sexually transmitted diseases

KW - substance abuse

UR - http://www.scopus.com/inward/record.url?scp=0027410579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027410579&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 730

EP - 735

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -